158 related articles for article (PubMed ID: 34954095)
1. Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.
McKinnon JE; Wang DD; Zervos M; Saval M; Marshall-Nightengale L; Kilgore P; Pabla P; Szandzik E; Maksimowicz-McKinnon K; O'Neill WW
Int J Infect Dis; 2022 Mar; 116():167-173. PubMed ID: 34954095
[TBL] [Abstract][Full Text] [Related]
2. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).
Naggie S; Milstone A; Castro M; Collins SP; Lakshmi S; Anderson DJ; Cahuayme-Zuniga L; Turner KB; Cohen LW; Currier J; Fraulo E; Friedland A; Garg J; George A; Mulder H; Olson RE; O'Brien EC; Rothman RL; Shenkman E; Shostak J; Woods CW; Anstrom KJ; Hernandez AF;
Int J Infect Dis; 2023 Apr; 129():40-48. PubMed ID: 36682681
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial.
Tirupakuzhi Vijayaraghavan BK; Jha V; Rajbhandari D; Myatra SN; John O; Ghosh A; Bassi A; Arfin S; Kunigari M; Joshi R; Donaldson L; Hammond N; Venkatesh B;
Trials; 2020 Aug; 21(1):754. PubMed ID: 32867852
[TBL] [Abstract][Full Text] [Related]
8. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M
Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039
[TBL] [Abstract][Full Text] [Related]
9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
10. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of hydroxychloroquine for treatment of mild SARS-CoV-2 infection and prevention of COVID-19 severity in pregnant and postpartum women: A randomized, double-blind, placebo-controlled trial.
González R; Goncé A; Gil MDM; Mazarico E; Ferriols-Pérez E; Toro P; Llurba E; Saéz E; Rodríguez-Zambrano MÁ; García-Otero L; López M; Santacruz B; Román MÁ; Payà A; Alonso S; Cruz-Lemini M; Pons-Duran C; Herrera LB; Chen H; Bardají A; Quintó L; Menendez C;
Acta Obstet Gynecol Scand; 2024 Mar; 103(3):602-610. PubMed ID: 38098221
[TBL] [Abstract][Full Text] [Related]
12. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial.
Grau-Pujol B; Camprubí-Ferrer D; Marti-Soler H; Fernández-Pardos M; Carreras-Abad C; Andrés MV; Ferrer E; Muelas-Fernandez M; Jullien S; Barilaro G; Ajanovic S; Vera I; Moreno L; Gonzalez-Redondo E; Cortes-Serra N; Roldán M; Arcos AA; Mur I; Domingo P; Garcia F; Guinovart C; Muñoz J
Trials; 2021 Nov; 22(1):808. PubMed ID: 34781981
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial.
Llanos-Cuentas A; Schwalb A; Quintana JL; Delfin B; Alvarez F; Ugarte-Gil C; Guerra Gronerth RI; Lucchetti A; Grogl M; Gotuzzo E
BMC Res Notes; 2023 Feb; 16(1):22. PubMed ID: 36849996
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial.
Agusti A; Guillen E; Ayora A; Anton A; Aguilera C; Vidal X; Andres C; Alonso M; Espuga M; Esperalba J; Gorgas MQ; Almirante B; Ribera E
Enferm Infecc Microbiol Clin (Engl Ed); 2022; 40(6):289-295. PubMed ID: 35680347
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials.
Hong H; Friedland A; Hu M; Anstrom KJ; Halabi S; McKinnon JE; Amaravadi R; Rojas-Serrano J; Abella BS; Portillo-Vázquez AM; Woods CW; Hernandez AF; Boulware DR; Naggie S; Rajasingham R
BMJ Open; 2023 Jun; 13(6):e065305. PubMed ID: 37328184
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
18. The 'myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19' is far from reality.
Dhibar DP; Arora N; Chaudhary D; Prakash A; Medhi B; Singla N; Mohindra R; Suri V; Bhalla A; Sharma N; Singh MP; Lakshmi PVM; Goyal K; Ghosh A
Sci Rep; 2023 Jan; 13(1):378. PubMed ID: 36611040
[TBL] [Abstract][Full Text] [Related]
19. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial.
Johnston C; Brown ER; Stewart J; Karita HCS; Kissinger PJ; Dwyer J; Hosek S; Oyedele T; Paasche-Orlow MK; Paolino K; Heller KB; Leingang H; Haugen HS; Dong TQ; Bershteyn A; Sridhar AR; Poole J; Noseworthy PA; Ackerman MJ; Morrison S; Greninger AL; Huang ML; Jerome KR; Wener MH; Wald A; Schiffer JT; Celum C; Chu HY; Barnabas RV; Baeten JM;
EClinicalMedicine; 2021 Mar; 33():100773. PubMed ID: 33681731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]